Sally Adams1,2. 1. Department of Psychology, University of Bath, 10 West, Bath, BA2 7AY UK. 2. UK Centre for Tobacco and Alcohol Studies, Bath, UK.
Abstract
PURPOSE OF THE REVIEW: Comorbidity of alcohol and tobacco use is highly prevalent and may exacerbate the health effects of either substance alone. However, the mechanisms underlying this comorbidity are not well understood. This review will examine the evidence for shared neurobiological mechanisms of alcohol and nicotine comorbidity and experimental studies of the behavioural consequences of these interactions. RECENT FINDINGS: Studies examining the shared neurobiology of alcohol and nicotine have identified two main mechanisms of comorbidity: (1) cross-reinforcement via the mesolimbic dopamine pathway and (2) cross-tolerance via shared genetic and nAChR interaction. Animal and human psychopharmacological studies demonstrate support for these two mechanisms of comorbidity. SUMMARY: Human behavioural studies indicate that (1) alcohol and tobacco potentiate each other's rewarding effects and (2) nicotine reduces the sedative and intoxication effects of alcohol. Together, these findings provide a strong evidence base to support the role of the cross-reinforcement and cross-tolerance as mechanisms underlying the comorbidity of alcohol and tobacco use. Methodological concerns in the literature and recommendations for future studies are discussed alongside implications for treatment of comorbid alcohol and tobacco use.
PURPOSE OF THE REVIEW: Comorbidity of alcohol and tobacco use is highly prevalent and may exacerbate the health effects of either substance alone. However, the mechanisms underlying this comorbidity are not well understood. This review will examine the evidence for shared neurobiological mechanisms of alcohol and nicotine comorbidity and experimental studies of the behavioural consequences of these interactions. RECENT FINDINGS: Studies examining the shared neurobiology of alcohol and nicotine have identified two main mechanisms of comorbidity: (1) cross-reinforcement via the mesolimbic dopamine pathway and (2) cross-tolerance via shared genetic and nAChR interaction. Animal and human psychopharmacological studies demonstrate support for these two mechanisms of comorbidity. SUMMARY:Human behavioural studies indicate that (1) alcohol and tobacco potentiate each other's rewarding effects and (2) nicotine reduces the sedative and intoxication effects of alcohol. Together, these findings provide a strong evidence base to support the role of the cross-reinforcement and cross-tolerance as mechanisms underlying the comorbidity of alcohol and tobacco use. Methodological concerns in the literature and recommendations for future studies are discussed alongside implications for treatment of comorbid alcohol and tobacco use.
Authors: T Z Zheng; P Boyle; H F Hu; J Duan; P J Jiang; D Q Ma; L P Shui; S R Niu; B MacMahon Journal: Cancer Causes Control Date: 1990-09 Impact factor: 2.506
Authors: S Franceschi; R Talamini; S Barra; A E Barón; E Negri; E Bidoli; D Serraino; C La Vecchia Journal: Cancer Res Date: 1990-10-15 Impact factor: 12.701
Authors: Andrea H Weinberger; Lauren R Pacek; Daniel Giovenco; Sandro Galea; Michael J Zvolensky; Misato Gbedemah; Renee D Goodwin Journal: Alcohol Clin Exp Res Date: 2018-12-10 Impact factor: 3.455
Authors: Marcus M Weera; Molly A Fields; Danielle N Tapp; Nicholas J Grahame; Julia A Chester Journal: Alcohol Clin Exp Res Date: 2018-01-15 Impact factor: 3.455
Authors: Scott T Barrett; Brady M Thompson; Jessica R Emory; Chris E Larsen; Steven T Pittenger; Edward N Harris; Rick A Bevins Journal: Nicotine Tob Res Date: 2020-02-06 Impact factor: 4.244
Authors: Maria Alice Pimentel Falcão; Lucas Santos de Souza; Silvio Santana Dolabella; Adriana Gibara Guimarães; Cristiani Isabel Banderó Walker Journal: Environ Sci Pollut Res Int Date: 2018-10-24 Impact factor: 4.223
Authors: Kristina L Bailey; Harry Smith; Susan K Mathai; Jonathan Huber; Mark Yacoub; Ivana V Yang; Todd A Wyatt; Katerina Kechris; Ellen L Burnham Journal: Alcohol Clin Exp Res Date: 2020-07-01 Impact factor: 3.455